Crescom

(Photo provided by Crescom Co., Ltd.)

On June 3rd, the Knee Joint Symposium was hosted by Boramae Medical Center and the Korean Society of Knee Joint at Seoul National University Boramae Medical Center. During the event, Jae Joon Lee, CEO of Crescom, presented on the topic of 'K-L Grade Assessment AI Solution'. During the presentation, MediAI-OA was introduced as an artificial intelligence solution for the quantitative analysis of degenerative arthritis stages in the knee joint. This innovative technology was built and piloted in the Health Insurance Review and Assessment Service's review support system with the support of the Ministry of Science and ICT.

The symposium was held with the goal of gaining a comprehensive understanding of the screening criteria for knee joint treatment used by the Health Insurance Review and Assessment Service. The aim of this symposium is to bridge the gap between clinical treatment and the screening process and propose practical measures for improvement. Crescom's MediAI-OA addresses the challenge of objectively evaluating the degree of joint space narrowing, which is difficult to evaluate with the naked eye. This innovative technology provides quantitative measurements and classifications of joint space narrowing, using artificial intelligence to compare them to normal standards.

Many doctors who attended this symposium expressed a high level of interest in MediAI-OA, which is used for screening by the Health Insurance Review and Assessment (HIRA) Service. Crescom's CEO, Jae Joon Lee, said that he expects this artificial intelligence solution to enhance the medical field's ability to read more quickly and accurately. He also expects that this AI solution will help the review process of the knee arthritis stage by the Health Insurance Review and Assessment (HIRA) Service.